Your browser doesn't support javascript.
loading
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study.
Bonnefoi, H; Jacot, W; Saghatchian, M; Moldovan, C; Venat-Bouvet, L; Zaman, K; Matos, E; Petit, T; Bodmer, A; Quenel-Tueux, N; Chakiba, C; Vuylsteke, P; Jerusalem, G; Brain, E; Tredan, O; Messina, C G M; Slaets, L; Cameron, D.
Afiliação
  • Bonnefoi H; Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux h.bonnefoi@bordeaux.unicancer.fr.
  • Jacot W; Department of Medical Oncology, Centre Val D'Aurelle-Paul Lamarque, Montpellier.
  • Saghatchian M; Department of Medical Oncology, Gustave Roussy, Villejuif.
  • Moldovan C; Department of Medical Oncology, Centre Henri Becquerel, Rouen.
  • Venat-Bouvet L; Department of Medical Oncology, Centre Hospitalier Universitaire, Limoges, France.
  • Zaman K; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Matos E; Department of Medical Oncology, Institute of Oncology, Ljubljana, Ljubljana University Clinic, Golnik, Slovenia.
  • Petit T; Department of Medical Oncology, Centre Paul Strauss, Strasbourg, France.
  • Bodmer A; Gyneco-Oncology Unit, Hôpitaux Universitaires de Genève (HUG), Geneva, Switzerland.
  • Quenel-Tueux N; Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux.
  • Chakiba C; Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux.
  • Vuylsteke P; Department of Medical Oncology, Hôpital St Elisabeth, Namur.
  • Jerusalem G; Department of Medical Oncology, Centre Hospitalier Universitaire (Sart Tilman), Liege, Belgium.
  • Brain E; Medical Oncology and Clinical Research Unit, Ensemble Hospitalier de L'Institut Curie, Hôpital René Huguenin, St-Cloud.
  • Tredan O; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Messina CG; Department of Statistics, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
  • Slaets L; Department of Statistics, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
  • Cameron D; Edinburgh Breast Unit and Edinburgh University Cancer Research Centre, Western General Hospital, Edinburgh, UK.
Ann Oncol ; 26(2): 325-32, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25467016
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adjuvante / Terapia Neoadjuvante Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adjuvante / Terapia Neoadjuvante Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article